What is it about?
Hepatitis C virus (HCV) is very good at escaping the immune system. One reason is a highly variable and immunodominant stretch in its virus surface antigen, called hypervariable region 1 (HVR1). We used a virus neutralizing antibody to study HVR1’s structure and how it is displayed on the viral antigen with X-ray crystallography and electron microscopy, and to test how it affects antibody neutralization and receptor binding. Our results show that HVR1 stays flexible even when antibodies are bound, and that it can shield conserved sites on the virus from neutralizing antibodies while also influencing how the virus engages its cell receptors. We propose the term “viral dial” to describe the behavior of this virus element, which may let the virus adapt to its environment, such as the host immune response, to survive.
Featured Image
Photo by National Institute of Allergy and Infectious Diseases on Unsplash
Why is it important?
HVR1 is both highly flexible and a main target of the immune response, which makes it a challenge for HCV vaccine design. We found that anti-HVR1 antibody can weaken the effect of neutralizing antibodies that target conserved parts of the virus . The antibody can also alter the virus’s preference of binding to different cell receptors. These findings show that the immunodominant antibodies against HVR1 can interfere with cross-neutralizing antibodies, which should be addressed when designing a HCV vaccine.
Perspectives
It was fascinating to look at HVR1 through so many different assays. It’s the first time I used electron microscopy to see the flexible molecular element of a virus and also used the combined antibodies to see how it could decrease instead of helping the virus neutralizations. This study really helps us think about this multifunctional element of HCV and provide a better basis for considering its impact on vaccine design.
Shr-Hau Hung
Scripps Research Institute
Read the Original
This page is a summary of: Structural basis of hypervariable region 1 dynamics on HCV envelope glycoproteins in immune evasion, Proceedings of the National Academy of Sciences, November 2026, Proceedings of the National Academy of Sciences,
DOI: 10.1073/pnas.2606727123.
You can read the full text:
Contributors
The following have contributed to this page







